FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...